Rheumatology & Immunology 2022 Year in Review

Dr. Jim Oates

As the director of the Division of Rheumatology and Immunology, I am proud of the unwavering commitment to patient care exhibited by the division faculty members, fellows, and clinical staff over the past year. This report highlights our most important breakthroughs and accomplishments of 2022 and the outcomes and innovations that make us a national leader in in the treatment of rheumatic diseases.

Highlights of the past year include:

In my service as the chair of the Division Directors Committee to the American College of Rheumatology, I have seen on a national scale how the current environment poses challenges to academic rheumatology. However, we look forward to meeting those challenges with our new vasculitis center, patient outreach efforts, and programs to address health disparities.

With profound gratitude,

Jim Oates, M.D.
Director, MUSC Division of Rheumatology & Immunology